DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Arnason JE, Luptakova K, Rosenblatt J. et al.
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.
Acta Haematol 2015;
133 (04) 347-353
We do not assume any responsibility for the contents of the web pages of other providers.